Publisert 18.12.2018

New EPO Patent granted 2018

New EPO patent

The European Patent Office has issued an additional  patent covering Regenics AS proprietary technology. The patent was granted on December 18th, 2018. Entitled: "COMPOSITION FOR USE IN WOUND HEALING "EPO No. 2656832 from EPO divisional patent application No. 1217881.5 Patent expiration date is May 11th, 2027.

 See also: Other patent news

More info: Christian Clemm, CMO at cc@regenics.no or mobile +47 95892548

 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.